Abstract
OBJECTIVE: To describe the clinical features and outcome of patients with toxic epidermal necrolysis. DESIGN: Case series. SETTING: Ross Tilley Burn Centre, Wellesley Hospital, Toronto. PATIENTS: Ten patients (seven women) with toxic epidermal necrolysis referred to the centre from 1984 to 1990. INTERVENTION: Biobrane (Winthrop Pharmaceuticals, New York) was applied to all raw surfaces after the epidermis had been completely separated. It was not removed until the epidermis had regenerated. MAIN RESULTS: The age of the patients varied from 27 to 90 (mean 45) years. The proportion of body surface area involved was 20% to 95% (mean 58.5%). Nine of the patients had received steroids and antibiotics prophylactically before being referred to the burn centre; the steroids were immediately tapered and the antibiotics withdrawn unless there was a specific infection. Urinary tract infection developed in seven patients, respiratory failure in six and systemic sepsis in six. All of the patients ultimately required antibiotics for treatment of systemic infections. Two patients died; both had severe illness before the onset of the toxic epidermal necrolysis. Biobrane provided a marked reduction in pain, eliminated the need for further dressings and allowed early, aggressive physiotherapy. The wounds healed completely within 14 to 21 days, with no significant scarring or need for skin grafting. CONCLUSIONS: The use of a temporary skin substitute is recommended for the treatment of toxic epidermal necrolysis. There is no indication for prophylactic steroid or antibiotic therapy; indeed, such therapy is probably contraindicated.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Halebian P. H., Corder V. J., Madden M. R., Finklestein J. L., Shires G. T. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986 Nov;204(5):503–512. doi: 10.1097/00000658-198611000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heimbach D. M., Engrav L. H., Marvin J. A., Harnar T. J., Grube B. J. Toxic epidermal necrolysis. A step forward in treatment. JAMA. 1987 Apr 24;257(16):2171–2175. [PubMed] [Google Scholar]
- LYELL A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956 Nov;68(11):355–361. doi: 10.1111/j.1365-2133.1956.tb12766.x. [DOI] [PubMed] [Google Scholar]
- Phillips L. G., Robson M. C., Smith D. J., Phillips W. A., Gracia W. D., McHugh T. P., Sullivan W. G., Mathoney K., Swartz K., Meltzer T. Uses and abuses of a biosynthetic dressing for partial skin thickness burns. Burns. 1989 Aug;15(4):254–256. doi: 10.1016/0305-4179(89)90044-2. [DOI] [PubMed] [Google Scholar]
- Rasmussen J. Toxic epidermal necrolysis. Med Clin North Am. 1980 Sep;64(5):901–920. doi: 10.1016/s0025-7125(16)31573-5. [DOI] [PubMed] [Google Scholar]
- Westly E. D., Wechsler H. L. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol. 1984 Jun;120(6):721–726. doi: 10.1001/archderm.120.6.721. [DOI] [PubMed] [Google Scholar]